Prostate cancer Board decisions

The Board has found that the VA medical opinions provided were inadequate and remanded for further development, including obtaining new medical opinions on the nature and etiology of the Veteran's heart disorder and prostate cancer.

The Board has restored a 30 percent rating for ischemic heart disease, denied the TDIU claim prior to August 3, 2017, dismissed the TDIU claim on or after August 3, 2017, and granted eligibility for Dependents' Educational Assistance (DEA) effective March 18, 2017.

Service connection for Persistent Depressive Disorder and Generalized Anxiety Disorder is granted.,Service connection for a skin condition other than PFB, including Psoriasis and Seborrheic Dermatitis, is denied.

The Veteran's claim for hepatitis C was denied due to lack of evidence linking the condition to service. The new evidence submitted does not relate to this issue.,Prostate cancer was denied as there is no evidence of in-service exposure or a link to Agent Orange exposure, and the preponderance of evidence does not support a finding that prostate cancer is related to service.,Type II diabetes mellitus was denied due to lack of evidence linking it to service. The Veteran's claim for hearing loss was also denied.,Low back disorder was denied as there is no evidence of a chronic condition in service or a link to service, and the Veteran did not provide sufficient evidence to reopen his low back disorder claim.,The Veteran's hearing loss claim was denied.

The Veteran's requests to reopen service connection claims for various conditions were denied. The Board also remanded several issues, including a low back disability rating and hypertension rating.

The Board denied service connection for prostate cancer with voiding dysfunction and right below the knee amputation, residual osteogenic sarcoma of the calcaneus. The claim for special monthly compensation based on loss of use of a creative organ was also denied.

The Veteran's prostate cancer disability rating was restored from 30% to 100% effective June 1, 2011.

The Board denied the Veteran's claim for a rating in excess of 20% for his prostate cancer residuals, finding that he is not entitled to such a rating based on the evidence of record. The reduction from 100% to 20% was upheld as appropriate under VA regulations.

The Veteran's service-connected prostate cancer and vertebral metastasis do not meet the criteria for eligibility for specially adapted housing due to their permanent and total disability status.

The Veteran's prostate cancer is granted service connection due to presumed exposure to herbicide agents during his military service in Thailand.

The Veteran's claims for effective dates prior to January 23, 2019 for service-connected prostate cancer residuals status post prostatectomy, scar lower abdomen as secondary to service-connected prostate cancer residuals, and erectile dysfunction as secondary to service-connected prostate cancer residuals were denied.,The Veteran's claim for special monthly compensation based on loss of use of a creative organ was also denied.

The Veteran's service connection claims for ischemic heart disease and prostate cancer were denied as there was no evidence of in-service exposure to herbicides or other conditions that would support a grant of service connection.

The Board has remanded the cases for additional development regarding the Veteran's claims of service connection for ischemic heart disease, diabetes, and prostate cancer due to potential exposure to Agent Orange during his time in Thailand.

The Veteran is granted a total disability rating for compensation purposes based on individual unemployability due to service-connected disabilities.

The Veteran's bladder cancer is granted service connection due to presumed exposure at Camp LeJeune. The lung, prostate, and skin (melanoma) cancers are remanded for further evaluation.

The Veteran's appeal for an increased rating for prostate cancer residuals has been dismissed due to his death.

The Board has denied the Veteran's claims for service connection for obstructive sleep apnea, an acquired psychiatric condition (depression), erectile dysfunction secondary to prostate cancer status post radical prostatectomy, diabetes mellitus, Type II, and prostate cancer. The Board also found that new evidence was not sufficient to reopen his claim for a bilateral foot condition.

The Board has decided that the reduction in the evaluation for residuals of prostate cancer from 100 percent to 40 percent was improper and remanded the matter.

The Board has remanded the case due to insufficient evidence regarding whether exposure to contaminated water at Camp Lejeune is related to any current disabilities, including respiratory failure, bowel obstruction, gastroesophageal cancer, and prostate cancer.